Zoladex 3.6 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zoladex 3.6 mg, covering 2007-06-26 to 2007-06-26. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer [NA]